Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation
Study assessing feasibility of further research relating to oral cannabinoid consumption and inflamation amongst people living with HIV
View Publication